Events

European Info Days on Horizon Europe Cluster 6 – 2022 calls
OCT
Mon
25
OCT
Tue
26

This was 4 years ago

Location

Online

Programmes
Agro-Food, Environment

The next edition of the Horizon Europe Cluster 6 Info-Days has been confirmed for 25-26 October. The European Commission will present the topics of the 2022 calls of the Cluster 6 Work Programme (Food, Bioeconomy, Natural Resources, Agriculture and Environment) and will give an insight about the Horizon Europe Mission ‘Soil health and food’.

Registration for the event is open here.

More information can be found on the event website.

The Cluster 6 Info-Days will be followed by a brokerage event on 27 October that will be dedicated to consortium building in Cluster 6.

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.